Depression and anxiety are thought to increase a person's risk of developing cancer, but research results have been inconclusive. In an analysis of multiple studies from the Netherlands, the United Kingdom, Norway, and Canada, ...
Aug 7, 2023
0
10
Warfarin, a widely used blood thinner, appears to have potent anti-cancer properties, according to a study by Columbia University researchers. The study, conducted in human cells and in mice, found that warfarin stops tumors ...
Aug 4, 2023
0
604
Researchers from A*STAR's Institute of Molecular and Cell Biology (IMCB) and National Cancer Centre Singapore (NCCS) have discovered how the loss of a gene, PBRM1, can lead to the development of kidney cancer. The work is ...
Jul 28, 2023
0
54
A new study led by researchers at The University of Texas MD Anderson Cancer Center has discovered that loss of metabolic fitness in chimeric antigen receptor (CAR) natural killer (NK) cells is a critical mechanism of resistance, ...
Jul 26, 2023
0
68
A surprising finding from USC reveals key details about how cancer cells metastasize and suggests new therapeutic approaches for halting their spread.
Jul 24, 2023
0
116
For nearly every disease, age is a major risk factor, and cancer is no exception. Between the ages of 25 and 65, an individual's risk of developing cancer skyrockets by 4,000%. A new study explores a "fingerprint" in cells ...
Jul 24, 2023
0
20
Cancer is one of the most devastating diseases in the world. In 2023, more than 1.9 million new cancer cases and 609,820 deaths are projected to occur in the United States alone. As efforts are underway to improve diagnostic ...
Jul 20, 2023
0
45
One in eight women will develop breast cancer in their lifetime. The disease is treatable, especially when caught early. But what is the impact of breast cancer later in life? A Moffitt Cancer Center researcher, in collaboration ...
Jul 19, 2023
0
26
A research team led by Northwestern University and the University of Pennsylvania scientists has created a new synthetic biology approach, a "QR code for cancer cells," to follow tumor cells over time, finding there are meaningful ...
Jul 19, 2023
0
52
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University's Lombardi Comprehensive ...
Jul 18, 2023
0
44
